Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial-processing peptidase subunit beta (PMPCB)
- Target
- PMPCB
- Molecular classification
- Enzyme, Metalloendopeptidase, Peptidase M16 family
01
Overview
Mitochondrial-processing peptidase beta subunit (PMPCB) is the catalytic component of the mitochondrial processing peptidase (MPP) complex, a heterodimer comprised of alpha and beta subunits. Located in the mitochondrial matrix, PMPCB contains a zinc-binding motif that is essential for enzyme activity. It specifically cleaves off N-terminal targeting sequences from mitochondrial precursor proteins to enable proper folding and function. The activity of PMPCB is fundamental for mitochondrial protein homeostasis, and its dysfunction is directly linked to severe inherited mitochondrial diseases. As an enzyme, it is classified among metalloendopeptidases and belongs to the peptidase M16 family.
- Other names
- Peptidase, mitochondrial processing subunit betaPMPCBmppBMPPβ
02
Mechanism of action
No approved drugs; theoretical approaches would inhibit or modulate its enzymatic cleavage activity within mitochondrial protein import pathways
03
Biological functions
Cleavage of N-terminal leader peptides from imported mitochondrial precursor proteinsProtein maturation in mitochondriaMaintenance of mitochondrial homeostasisRegulation of mitochondrial protein import
04
Disease associations
Multiple mitochondrial dysfunctions syndromeNeurodegenerative disease (involvement in PINK1 regulation affecting Parkinson's disease pathways)Mitochondrial disease
05
Safety considerations
Loss or mutation leads to severe mitochondrial dysfunction, which can be lethalDisrupting PMPCB activity can result in impaired ATP production, increased cell death, and neurodegeneration
06
Biomarkers
Mutations or dysfunctional activity of PMPCB serve as biomarkers for some mitochondrial disorders, including Multiple Mitochondrial Dysfunctions Syndrome 6
Beyond the preview
Go deeper on Mitochondrial-processing peptidase subunit beta (PMPCB).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitochondrial-processing peptidase subunit beta (PMPCB).